Probiotics: A Promising Candidate for Management of Colorectal Cancer
Colorectal cancer (CRC) is the World’s third most frequently diagnosed cancer type. It accounted for about 9.4% mortality out of the total incidences of cancer in the year 2020. According to estimated facts by World Health Organization (WHO), by 2030, 27 million new CRC cases, 17 million deaths, and...
Main Authors: | Ashutosh Tripathy, Jayalaxmi Dash, Sudhakar Kancharla, Prachetha Kolli, Deviyani Mahajan, Shantibhusan Senapati, Manoj Kumar Jena |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/13/3178 |
Similar Items
-
Bioengineered probiotics to control SARS-CoV-2 infection
by: Shantibhusan Senapati, et al.
Published: (2020-05-01) -
In Silico exploration of phytochemicals as potential drug candidates against dipeptidyl peptidase-4 target for the treatment of type 2 diabetes
by: Sanjeev Singh, et al.
Published: (2023-01-01) -
Reverse vaccinology approach towards the in-silico multiepitope vaccine development against SARS-CoV-2 [version 1; peer review: 2 approved]
by: Vipul Kumar, et al.
Published: (2021-01-01) -
Role of Natural Killer Cells during Pregnancy and Related Complications
by: Deviyani Mahajan, et al.
Published: (2022-01-01) -
Promising immunonutrients in general medical practice
by: M A Sheviakov, et al.
Published: (2014-02-01)